Live feed
Filing
SC 13G/A
SC 13G/A0001623632-23-000216·CASI Pharmaceuticals, Inc (DE)
Schedule 13G ownership disclosure
CASI PHARMACEUTICALS INC
Security class unavailable · CUSIP: 14757U208
Event date: 2022-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 6.6200%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001623632-23-000216
- Form type
- SC 13G/A
- Filer
- CASI Pharmaceuticals, Inc (DE)
- CIK
- CIK 895051
- Filed
- Feb 01, 2023
- Reporting period
- Dec 31, 2022
- Description
- Schedule 13G beneficial ownership